RhumbLine Advisers
MXCT icon

RhumbLine Advisers’s MaxCyte MXCT Stock Holding History

RhumbLine Advisers’s Portfolio MXCT Stock Details MXCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$59K Sell
47,973
-74,321
-61% -$74.1K ﹤0.01% 3654
2026
Q1 		$85.8K Sell
122,294
-15,839
-11% -$14.8K ﹤0.01% 3463
2025
Q4 		$214K Sell
138,133
-10,484
-7% -$16.7K ﹤0.01% 3153
2025
Q3 		$235K Sell
148,617
-1,843
-1% -$3.2K ﹤0.01% 3144
2025
Q2 		$328K Sell
150,460
-2,574
-2% -$6.23K ﹤0.01% 2931
2025
Q1 		$418K Sell
153,034
-621
-0.4% -$2.45K ﹤0.01% 2684
2024
Q4 		$639K Buy
153,655
+2,402
+2% +$9.08K ﹤0.01% 2508
2024
Q3 		$588K Sell
151,253
-6,363
-4% -$26.8K ﹤0.01% 2593
2024
Q2 		$618K Buy
157,616
+20,864
+15% +$89.8K ﹤0.01% 2521
2024
Q1 		$573K Buy
136,752
+3,901
+3% +$18.3K ﹤0.01% 2579
2023
Q4 		$624K Buy
132,851
+1,443
+1% +$5.62K ﹤0.01% 2537
2023
Q3 		$410K Sell
131,408
-91
-0.1% -$366 ﹤0.01% 2729
2023
Q2 		$604K Sell
131,499
-3,644
-3% -$16.7K ﹤0.01% 2574
2023
Q1 		$669K Buy
135,143
+7,072
+6% +$34.8K ﹤0.01% 2304
2022
Q4 		$699K Buy
128,071
+1,484
+1% +$9.1K ﹤0.01% 2307
2022
Q3 		$823K Buy
126,587
+7,403
+6% +$41.3K ﹤0.01% 2250
2022
Q2 		$564K Buy
119,184
+14,306
+14% +$70.5K ﹤0.01% 2436
2022
Q1 		$733K Buy
104,878
+11,184
+12% +$76.4K ﹤0.01% 2260
2021
Q4 		$955K Buy
93,694
+82,957
+773% +$891K ﹤0.01% 2234
2021
Q3 		$131K Buy
+10,737
New +$162K ﹤0.01% 2968

Other funds holding MXCT

CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
VP
Vitruvian Partners London, United Kingdom $201M AUM 10.44% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
MA
Mudita Advisors London, United Kingdom $481M AUM 73.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BFM
Brooklands Fund Management London, United Kingdom $128M AUM
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
PLC
Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return

RhumbLine Advisers's MXCT Position: Q2 2026 in Review

RhumbLine Advisers reduced its MaxCyte (MXCT) stake by 61% in Q2 2026, selling an estimated $74.1K and leaving 47,973 shares worth $59K. The position accounts for ﹤0.01% of the portfolio, ranked #3654.

RhumbLine Advisers first reported a position in MXCT in Q3 2021 and has held it in 20 quarters since. The position peaked at $955K in Q4 2021. 122 funds tracked by Wall St. Rank hold MXCT as of Q2 2026.

  • RhumbLine Advisers held 47,973 shares of MaxCyte worth $59K as of Q2 2026.
  • RhumbLine Advisers sold 74,321 MaxCyte shares in Q2 2026, an estimated $74.1K.
  • MaxCyte made up ﹤0.01% of RhumbLine Advisers's portfolio in Q2 2026, its #3654 holding.
  • RhumbLine Advisers first reported a position in MaxCyte in Q3 2021 and has held it in 20 quarters since.
  • RhumbLine Advisers's MaxCyte position peaked at $955K in Q4 2021.
  • 122 funds tracked by Wall St. Rank held MaxCyte as of Q2 2026.

Based on RhumbLine Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.